LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

Search

Pfizer

Closed

SectorHealthcare

26.02 1.36

Overview

Share price change

24h

Current

Min

26.01

Max

26.11

Key metrics

By Trading Economics

Income

623M

3.6B

Sales

2B

17B

P/E

Sector Avg

14.692

80.03

EPS

0.87

Dividend yield

6.6

Profit margin

21.322

Employees

81,000

EBITDA

325M

5.6B

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+12.53% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

6.60%

2.29%

Market Stats

By TradingEconomics

Market Cap

3.5B

144B

Previous open

24.66

Previous close

26.02

News Sentiment

By Acuity

40%

60%

143 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Pfizer Chart

Past performance is not a reliable indicator of future results.

Related News

13 Nov 2025, 17:39 UTC

Acquisitions, Mergers, Takeovers

Pfizer Completes Acquisition of Metsera

10 Nov 2025, 13:08 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

10 Nov 2025, 09:41 UTC

Acquisitions, Mergers, Takeovers

Novo Nordisk Shares Rise After Withdrawal of Metsera Takeover Battle

26 Nov 2025, 09:54 UTC

Hot Stocks

Stocks to Watch Wednesday: Dell, HP, Workday -- WSJ

17 Nov 2025, 18:20 UTC

Acquisitions, Mergers, Takeovers

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

14 Nov 2025, 12:22 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Pharma Sector Becoming Bidding Battlefield -- Market Talk

13 Nov 2025, 16:26 UTC

Acquisitions, Mergers, Takeovers

Pfizer Completes Acquisition Of Metsera >PFE

10 Nov 2025, 16:35 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Pfizer CEO Confident Metsera Therapies Will Get Approval -- Market Talk

10 Nov 2025, 16:26 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Pfizer CEO: Metsera Has Exciting Weight-Loss Portfolio -- Market Talk

10 Nov 2025, 15:36 UTC

Acquisitions, Mergers, Takeovers

What's Next for Novo Nordisk? -- WSJ

10 Nov 2025, 14:05 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Pfizer Will See Big Benefits from Metsera Acquisition -- Market Talk

10 Nov 2025, 12:33 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10 Nov 2025, 12:32 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10 Nov 2025, 10:45 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, CoreWeave, and More -- Barrons.com

10 Nov 2025, 10:34 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, CoreWeave, and More -- Barrons.com

10 Nov 2025, 10:32 UTC

Hot Stocks

Stocks to Watch Monday: Metsera, Novo Nordisk, Nvidia, Tyson Foods -- WSJ

10 Nov 2025, 09:26 UTC

Acquisitions, Mergers, Takeovers

Novo Nordisk Shares Rise After Withdrawal From Metsera Takeover Battle

8 Nov 2025, 13:10 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 Nov 2025, 03:50 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 Nov 2025, 03:41 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 Nov 2025, 03:07 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 Nov 2025, 13:26 UTC

Acquisitions, Mergers, Takeovers

Correction to This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. Article -- WSJ

7 Nov 2025, 10:30 UTC

Acquisitions, Mergers, Takeovers

This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. -- WSJ

6 Nov 2025, 20:02 UTC

Acquisitions, Mergers, Takeovers

Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments. -- Barrons.com

6 Nov 2025, 16:16 UTC

Earnings

Moderna's Quarter Wasn't As Bad as It Could Have Been. The Stock is Up -- Barrons.com

6 Nov 2025, 12:29 UTC

Earnings

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6 Nov 2025, 12:15 UTC

Earnings

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6 Nov 2025, 00:24 UTC

Acquisitions, Mergers, Takeovers

Metsera: Pfizer Has Reiterated It Will Continue to Litigate >MTSR

6 Nov 2025, 00:24 UTC

Acquisitions, Mergers, Takeovers

Metsera: Board of Directors Will Continue to Stand Firm on Behalf of Shareholders, Patients >MTSR

6 Nov 2025, 00:24 UTC

Acquisitions, Mergers, Takeovers

Metsera: Gratified by Court Decision to Deny Pfizer's Request for Temporary Restraining Order to Block Board From Acting in Shareholders' Best Interests >MTSR

Peer Comparison

Price change

Pfizer Forecast

Price Target

By TipRanks

12.53% upside

12 Months Forecast

Average 28.92 USD  12.53%

High 35 USD

Low 24 USD

Based on 16 Wall Street analysts offering 12 month price targets forPfizer - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

16 ratings

4

Buy

11

Hold

1

Sell

Technical Score

By Trading Central

22.855 / 23.85Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

143 / 374 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat